Open CFD account Free Demo
Call: +248 4 671 903 Mail: [email protected]
Log In Open Account
Log In Open Account
Log In Open Account
News & Analysis
Open Account
News & Analysis
Open Account

Amgen reports Q4 results

8 February 2022 By Klavs Valters

Share

Amgen Inc. (AMGN) reported its fourth-quarter financial results after the closing bell on Monday.

The US biotechnology company reported total revenue of $6.846 billion (a 3% increase from the same period in 2020), just shy of the analyst forecast of $6.868 billion.

Earnings per share was reported at $4.36 (up 26% year-over-year), beating analyst forecasts of $4.04 per share.

Total revenues reported at $26 billion in 2021 – up by 2% from the previous year.

Robert A. Bradway, Chairman, and Chief Executive Officer of Amgen commented on last year’s results: “We realized strong volume growth for many of our key products during last year.”

“These products, combined with our many pipeline opportunities, position us well for long-term growth,” Bradway added.

Amgen Inc. (AMGN) chart (Weekly)

Shares of Amgen little changed at the end of the trading day on Monday, up by 0.64% at $223.49 per share. Here is how the stock has performed in the past year –

  • 1 Month: -2.97%
  • 3 Month: +5.75%
  • Year-to-date: -0.64%
  • 1 Year: -5.91%

Amgen is the 107th largest company in the World, with a total market cap of $125.90 billion.

You can trade Amgen Inc. (AMGN) and many other stocks from the NYSE, NASDAQ, HKEX, and the ASX with GO Markets as a Share CFD.

Sources: Amgen Inc., TradingView, GO Markets MT5, CompaniesMarketCap

The information provided is of general nature only and does not take into account your personal objectives, financial situations or needs. Before acting on any information provided, you should consider whether the information is suitable for you and your personal circumstances and if necessary, seek appropriate professional advice. All opinions, conclusions, forecasts or recommendations are reasonably held at the time of compilation but are subject to change without notice. Past performance is not an indication of future performance. Go Markets Pty Ltd, ABN 85 081 864 039, AFSL 254963 is a CFD issuer, and trading carries significant risks and is not suitable for everyone. You do not own or have any interest in the rights to the underlying assets. You should consider the appropriateness by reviewing our TMD, FSG, PDS and other CFD legal documents to ensure you understand the risks before you invest in CFDs. These documents are available here.

#Economy #Economics #Finance #Markets